Skip to main content
search
Conference

2026 ISPE Annual Meeting

Conference: 2026 ISPE Annual Meeting

Date: August 29 - September 2, 2026

Location: Milan, Italy

Booth: 406

Learn more about Certara’s innovative approach to studying rare diseases

Addressing the complex challenges of rare disease drug development and evidence generation requires an innovative approach. Visit Certara at booth #406 at the 2026 ISPE Annual Meeting to connect with our real-world evidence and pharmacoepidemiology experts and learn how we’re linking rare disease registries with national health claims databases to overcome issues related to limited and incomplete data to help our customers assess the burden of illness.

Linking data to solve common yet complex challenges in studying rare disease

Certara’s experts help you overcome:

  • Limited data caused by inherently small patient populations
  • Fragmented, hard-to-find patients dispersed patient populations
  • Incomplete data sources that capture some outcomes and resource utilization but lack granular clinical measures or quality of life data

More information on posters and presentations coming soon

Explore Certara's RWE Services

  • Outcomes Research and Surveys: Analyzing treatment patterns, patient outcomes, and unmet needs in niche populations to inform development and market access strategies
  • Data Source Selection: Identifying and selecting the most appropriate real-world data sources (e.g., patient registries, medical records, claims data) to address specific research questions
  • Advanced Analytics and Modeling: Applying sophisticated analytical techniques to RWE to extract meaningful insights, including comparative effectiveness studies, cost-effectiveness analyses, and safety evaluations.
  • Regulatory Support: Providing regulatory writing, strategy, and submission expertise to support rare disease drug approvals.
  • Market Access Strategies: Developing strategies to optimize pricing, reimbursement, and market access for rare disease therapies.

Additional Resources

You May Also Like

Enhancing clinical trials with real-world evidence in pregnancy research
Enhancing clinical trials with real-world evidence in pregnancy researchBlog

Enhancing clinical trials with real-world evidence in pregnancy research

How to Build a Best Practice Global Value Dossier With a Decision-first Strategy
How to Build a Best Practice Global Value Dossier With a Decision-first StrategyGuide

How to Build a Best Practice Global Value Dossier With a Decision-first Strategy

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate DevelopmentAnnouncement

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development

Fact Sheet

From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.

Download now